Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

CNBX Pharmaceuticals (CNBX) Assets Average (2016 - 2025)

CNBX Pharmaceuticals (CNBX) has disclosed Assets Average for 13 consecutive years, with $14799.5 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 44.87% year-over-year to $14799.5, compared with a TTM value of $14799.5 through Nov 2025, down 44.87%, and an annual FY2025 reading of $24910.0, down 90.61% over the prior year.
  • Assets Average was $14799.5 for Q4 2025 at CNBX Pharmaceuticals, down from $18526.0 in the prior quarter.
  • Across five years, Assets Average topped out at $4.4 million in Q2 2021 and bottomed at $14799.5 in Q4 2025.
  • Average Assets Average over 5 years is $1.0 million, with a median of $548908.0 recorded in 2023.
  • The sharpest move saw Assets Average surged 32.7% in 2021, then plummeted 93.94% in 2024.
  • Year by year, Assets Average stood at $2.6 million in 2021, then tumbled by 72.67% to $710337.5 in 2022, then crashed by 37.6% to $443220.5 in 2023, then tumbled by 93.94% to $26845.5 in 2024, then plummeted by 44.87% to $14799.5 in 2025.
  • Business Quant data shows Assets Average for CNBX at $14799.5 in Q4 2025, $18526.0 in Q3 2025, and $34637.5 in Q2 2025.